GLPwatch

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

NCT07547878 · Not yet recruiting

Last updated 2026-05-28

This clinical trial is testing whether starting four recommended treatments at once is more effective at keeping people with chronic kidney disease and type 2 diabetes in the study after 6 months.

Status Not yet recruiting Approved but enrollment has not started.
Phase Phase 4 Monitors a drug already on the market.
Type Interventional (clinical trial)
Design Randomized, open-label (no blinding) treatment study
Participants 64 people Planned (estimated).
Who can join Ages 18–84 · all sexes
Timeline Started 2026-04 · est. completion 2029-03
Where 1 site · United States

What this study is testing ClinicalTrials.gov NCT07547878 ↗

Description as written by the study sponsor.

The goal of this clinical trial is to learn if starting four kidney disease medicines quickly and together (a rapid treatment approach) is safe and works well in people with type 2 diabetes and chronic kidney disease. The main questions it aims to answer are: * Is it safe to start these medicines over a short period of time? * How often do kidney function changes or high potassium levels occur? * Does this approach lower protein in the urine (a sign of kidney damage)? * How many participants are able to stay on all four medicines over 6 months? Researchers will compare this approach to usual care, where medicines are started one at a time over several months. Participants will: Be assigned by chance to either this approach or usual care Start up to four approved kidney medicines over about 8 weeks (rapid treatment approach) or follow standard care Have regular clinic visits and lab tests to check kidney function and potassium levels Be followed for about 6 months

Treatments tested

Main thing measuredOn-study retention rate at 6 months
SponsorBaylor Research Institute
Conditions studiedChronic Kidney Disease, Type 2 Diabetes
GLP-1 drugs

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07547878 ↗